Key result
This editorial summarizes 12 studies on cell death, cardiovascular injuries, and novel targets for cardiovascular therapeutics published in 2021.
Answers are grounded in this paper and cite their sources.
This editorial summarizes 12 recent studies on cell death and cardiovascular injuries to highlight novel targets in cardiovascular therapeutics.
With the effort and support of the authors, editorial office, and editorial team, the Frontiers in Cardiovascular Medicine, Cardiovascular Therapeutics Section-Research Topic “Insights in Cardiovascular Therapeutics: 2021” has achieved great success and is attracting interest from the cardiovascular community. Here, we spotlight 12 studies published in our section that related to cell death and cardiovascular injuries, as well as some recent advances in the field that have tremendous potential in cardiovascular therapy. In addition, these highlights may serve as the foundation for some new developments in our Cardiovascular Therapeutics areas. In 2022, we will keep working to create a fantastic platform for cardiologists, translational cardiovascular scientists, and cardiovascular pharmacological scientists to share new results and data in clinical cardiology and translational cardiovascular therapeutics.
No takes yet. Share an insight, caveat, or question.
Xu et al. (2022) conducted an editorial in Cardiovascular diseases. This editorial summarizes 12 studies on cell death, cardiovascular injuries, and novel targets for cardiovascular therapeutics published in 2021.
Synapse has enriched 10 related papers. Consider them for comparative context: